Lobbying Filing Details
Total Spending
$500,000
Activities
3
Lobbyists
2
Gov't Entities
6
Filing Information
- Filing UUID:
3b173ed8-c5ec-4f24-b65a-08c7e2b663f4- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2025 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 21, 2025 at 3:27 PM
- Income:
- $0
- Expenses:
- $500,000
- Expense Method:
- A
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals
Registrant
ACADIA PHARMACEUTICALS
Biopharmaceutical company
San Diego, CaliforniaClient
ACADIA PHARMACEUTICALS
California, United States of AmericaLobbying Activities (3)
Activity 1
Health IssuesImplementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Lobbyists (2)
- MR. MICHAEL MATTOON
- SARAH TELLOCK
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
Medicare/MedicaidImplementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).
Lobbyists (2)
- MR. MICHAEL MATTOON
- SARAH TELLOCK
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
Taxation/Internal Revenue CodeCameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Lobbyists (2)
- MR. MICHAEL MATTOON
- SARAH TELLOCK
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES